Biomedical research and development services in relation to the testing of biological samples to determine the presence and activity of stem cells, progenitor cells and liver cells, in particular, liver stem cells and liver progenitor cells Cells originating from human tissue, for medical, clinical or veterinary use, namely, liver derived cells and stem cells or liver progenitor cells; pharmaceut Read More

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Class [005]
Pharmaceutical Products

Cells originating from human tissue, for medical, clinical or veterinary use, namely, liver derived cells and stem cells or liver progenitor cells; pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of diseases that require cell therapy medicinal products, namely, liver diseases, chronic biliary diseases, cholestatic diseases, age-related diseases, bone and cartilage disorders, pancreatic diseases, kidney diseases, pulmonary diseases, cardiovascular diseases, eye diseases, ocular diseases, organ injury, organ failure, blood coagulation disorders, Clarkson disease, diabetes, skin diseases, cancer, metabolic diseases, inflammatory diseases, inflammation, neurodegenerative diseases, fibrotic diseases, proliferative diseases, infectious diseases, autoimmune diseases, diseases with unwanted immune response, sepsis, sepsis induced diseases, cellular senescence; surgical implants comprised of living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; transplants being living tissue in the form of liver derived cells and stem cells or liver progenitor cells; live organs and tissues for surgical purpose in the field of liver derived cells and stem cells or liver progenitor cells; surgical implants comprising living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; cell-based pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of liver diseases, chronic biliary diseases, cholestatic diseases, age-related diseases, bone and cartilage disorders, pancreatic diseases, kidney diseases, pulmonary diseases, cardiovascular diseases, eye diseases, ocular diseases, organ injury, organ failure, blood coagulation disorders, Clarkson disease, diabetes, skin diseases, cancer, metabolic diseases, inflammatory diseases, inflammation, neurodegenerative diseases, fibrotic diseases, proliferative diseases, infectious diseases, autoimmune diseases, diseases with unwanted immune response, sepsis, sepsis induced diseases, cellular senescence

Mark Details

Serial Number

No 79346877

Mark Type

No Service Mark

Attorney Docket Number

No HWING-T023-U

44D Filed

44D Current

44E filed

44E Current

66A Filed

Yes

66A Current

Yes

Current Basis

No Basis

Legal History

Status Date	Action Taken
11^th Mar 2024	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05^th Mar 2024	REGISTERED-PRINCIPAL REGISTER
05^th Mar 2024	NOTICE OF REGISTRATION CONFIRMATION EMAILED
21^st Feb 2024	NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21^st Feb 2024	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21^st Dec 2023	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21^st Dec 2023	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21^st Dec 2023	TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21^st Dec 2023	TEAS CHANGE OF CORRESPONDENCE RECEIVED
19^th Dec 2023	PUBLISHED FOR OPPOSITION

CELLAÏON